Dabur India Ltd shares fell 2% on Monday after the Securities and Exchange Board of India (SEBI) issued an administrative warning to the company over a delay in disclosing a warning letter received from the US Food and Drug Administration (USFDA) in July. The market regulator said the company had failed to make the disclosure within the prescribed timeline under SEBI's listing regulations.
According to the company's November 6 exchange filing, SEBI's warning relates to a letter issued by the USFDA on July 24, 2026. The regulator said Dabur had delayed informing the stock exchanges about the USFDA communication, amounting to a violation of Regulation 30(6)(iii) of the SEBI Listing Obligations and Disclosure Requirements (LODR) Regulations.
Dabur India shares touched a low of Rs 377.05 on Monday, down around 1.5% from their previous close of Rs 382.85. The stock opened at Rs 380.60 and touched a high of Rs 381.45 during the session.
In its November 6 communication, SEBI said the lapse had been viewed seriously and advised Dabur and its board to ensure that such delays do not recur. The regulator cautioned that any repetition of the violation could invite enforcement action under the SEBI Act, 1992, and the applicable rules and regulations.
SEBI has also asked the company to place the warning letter before its board of directors at the upcoming meeting and forward the board's comments on whether it is satisfied with the corrective measures taken to ensure future compliance. The regulator separately directed Dabur to disclose the administrative warning to the stock exchanges under Regulation 30.
What did Dabur say?
Dabur said it would take the necessary steps to address the concerns and directions mentioned in SEBI's letter. The company also maintained that it has consistently followed SEBI's listing requirements.
In its filing, Dabur clarified that the administrative warning has no financial or operational impact on the company. The communication was received by the company through email on November 6 at 12:40 pm.
Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.